Patents by Inventor Amar Lulla

Amar Lulla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Compositions
    Publication number: 20210308150
    Abstract: A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.
    Type: Application
    Filed: June 15, 2021
    Publication date: October 7, 2021
    Applicant: CIPLA Limited
    Inventors: Geena Malhotra, Shrinivas Madhukar Purandare, Amar Lulla
  • Pharmaceutical compositions
    Patent number: 11077124
    Abstract: A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.
    Type: Grant
    Filed: July 10, 2017
    Date of Patent: August 3, 2021
    Assignee: CIPLA Limited
    Inventors: Geena Malhotra, Shrinivas Madhukar Purandare, Amar Lulla
  • Combination of azelastine and fluticasone for nasal administration
    Patent number: 9901585
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: February 27, 2018
    Assignee: Cipla Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Pharmaceutical Compositions
    Publication number: 20170333452
    Abstract: A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.
    Type: Application
    Filed: July 10, 2017
    Publication date: November 23, 2017
    Applicant: CIPLA Limited
    Inventors: Geena Malhotra, Shrinivas Madhukar Purandare, Amar Lulla
  • Combination of Azelastine and Fluticasone for Nasal Administration
    Publication number: 20170035780
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Application
    Filed: March 15, 2016
    Publication date: February 9, 2017
    Inventors: Amar LULLA, Geena MALHOTRA
  • Pharmaceutical products and composition comprising specific anticholinergic agents, ?-2 agonists and corticosteroids
    Patent number: 9446054
    Abstract: This invention relates to pharmaceutical products and compositions for use in the treatment of asthma and related disorders, and especially but not exclusively for the treatment of chronic obstructive pulmonary disease (COPD). More particularly, the invention provides pharmaceutical products and compositions comprising specific anticholinergic agents, ?-2 agonists and corticosteroids.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: September 20, 2016
    Assignee: Cipla Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Anti-retroviral combination
    Patent number: 9339470
    Abstract: A pharmaceutical composition comprising a solid unit dosage form comprising: (i) ritonavir or a pharmaceutically acceptable salt and ester thereof; (ii) darunavir or a pharmaceutically acceptable salt and ester thereof.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: May 17, 2016
    Assignee: Cipla Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Combination of azelastine and fluticasone for nasal administration
    Patent number: 9259428
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: February 16, 2016
    Assignee: Cipla Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Combination of Azelastine and Fluticasone for Nasal Administration
    Publication number: 20150224116
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Application
    Filed: March 18, 2015
    Publication date: August 13, 2015
    Inventors: Amar LULLA, Geena MALHOTRA
  • Topical Foam Composition
    Publication number: 20150196488
    Abstract: A topical foam pharmaceutical composition for rectal administration comprising rifaximin is described. Also described is a method of making the composition and the use of the composition as a medicament.
    Type: Application
    Filed: March 25, 2015
    Publication date: July 16, 2015
    Applicant: CIPLA Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Combination of Azelastine and Fluticasone for Nasal Administration
    Publication number: 20150190405
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Application
    Filed: March 18, 2015
    Publication date: July 9, 2015
    Inventors: Amar LULLA, Geena MALHOTRA
  • PHARMACEUTICAL PRODUCTS AND COMPOSITION COMPRISING SPECIFIC ANTIOCHOLINERGIC AGENTS, BETA-2 AGONISTS AND CORTICOSTEROIDS
    Publication number: 20150098999
    Abstract: This invention relates to pharmaceutical products and compositions for use in the treatment of asthma and related disorders, and especially but not exclusively for the treatment of chronic obstructive pulmonary disease (COPD). More particularly, the invention provides pharmaceutical products and compositions comprising specific anticholinergic agents, ?-2 agonists and corticosteroids.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 9, 2015
    Inventors: Amar Lulla, Geena Malhotra
  • Combination of Azelastine and Mometasone for Nasal Administration
    Publication number: 20150072010
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Application
    Filed: November 12, 2014
    Publication date: March 12, 2015
    Inventors: Amar LULLA, Geena MALHOTRA
  • Pharmaceutical products and composition comprising specific anticholinergic agents, ?-2 agonists and corticosteroids
    Patent number: 8962601
    Abstract: This invention relates to pharmaceutical products and compositions for use in the treatment of asthma and related disorders, and especially but not exclusively for the treatment of chronic obstructive pulmonary disease (COPD). More particularly, the invention provides pharmaceutical products and compositions comprising specific anticholinergic agents, ?-2 agonists and corticosteroids.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: February 24, 2015
    Assignee: Cipla Ltd
    Inventors: Amar Lulla, Geena Malhotra
  • Combination of azelastine and mometasone for nasal administration
    Patent number: 8937057
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: January 20, 2015
    Assignee: Cipla Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Combination of azelastine and ciclesonide for nasal administration
    Patent number: 8933060
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: January 13, 2015
    Assignee: Cipla Limited
    Inventors: Amar Lulla, Geena Malhotra
  • TOPICAL COMPOSITION
    Publication number: 20140024693
    Abstract: A topical composition comprising: fipronil or a pharmaceutically acceptable salt thereof; at least one surfactant and at least one crystallization inhibitor for the treatment and protection of animals which are infested with parasites.
    Type: Application
    Filed: July 12, 2013
    Publication date: January 23, 2014
    Inventors: Geena MALHOTRA, Amar Lulla, Martin Benedict George Donnelly
  • Pharmaceutical Compositions
    Publication number: 20130330281
    Abstract: A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.
    Type: Application
    Filed: August 8, 2013
    Publication date: December 12, 2013
    Applicant: CIPLA Limited
    Inventors: Geena Malhotra, Shrinivas Madhukar Purandare, Amar Lulla
  • Topical Foam Composition
    Publication number: 20130315998
    Abstract: A topical foam pharmaceutical composition for rectal administration comprising rifaximin is described. Also described is a method of making the composition and the use of the composition as a medicament.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicant: CIPLA Limited
    Inventors: Amar Lulla, Geena Malhotra
  • Pharmaceutical Composition
    Publication number: 20130302415
    Abstract: A pharmaceutical composition comprising efavirenz wherein the efavirenz is in the form of nanoparticles is disclosed.
    Type: Application
    Filed: July 14, 2013
    Publication date: November 14, 2013
    Inventors: Amar Lulla, Geena Malhotra